Gene Editing Evidence that monoclonal antibodies can reduce COVID-19 (Delta) mortality Posted on January 17, 2022 by Editorial Staff Researchers prevent evidence on the efficacy of neutralizing monoclonal antibodies in treating COVID-19. Share on FacebookTweetFollow us Editorial Staff Effects of post-acute COVID-19 on physical and mental health in women SARS-CoV-2 interacts with heparan sulfate to activate the alternative pathway
